↓ Skip to main content

Neoantigen vaccine: an emerging tumor immunotherapy

Overview of attention for article published in Molecular Cancer, August 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#42 of 1,894)
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
3 news outlets
blogs
2 blogs
twitter
13 X users
video
1 YouTube creator

Citations

dimensions_citation
409 Dimensions

Readers on

mendeley
512 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neoantigen vaccine: an emerging tumor immunotherapy
Published in
Molecular Cancer, August 2019
DOI 10.1186/s12943-019-1055-6
Pubmed ID
Authors

Miao Peng, Yongzhen Mo, Yian Wang, Pan Wu, Yijie Zhang, Fang Xiong, Can Guo, Xu Wu, Yong Li, Xiaoling Li, Guiyuan Li, Wei Xiong, Zhaoyang Zeng

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 512 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 512 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 67 13%
Student > Ph. D. Student 64 13%
Student > Master 63 12%
Researcher 55 11%
Other 18 4%
Other 45 9%
Unknown 200 39%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 102 20%
Immunology and Microbiology 47 9%
Medicine and Dentistry 41 8%
Agricultural and Biological Sciences 36 7%
Pharmacology, Toxicology and Pharmaceutical Science 15 3%
Other 60 12%
Unknown 211 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 42. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 January 2024.
All research outputs
#968,571
of 25,168,110 outputs
Outputs from Molecular Cancer
#42
of 1,894 outputs
Outputs of similar age
#20,302
of 347,686 outputs
Outputs of similar age from Molecular Cancer
#1
of 16 outputs
Altmetric has tracked 25,168,110 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,894 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,686 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.